Go Pro

333,370 Shares in AMETEK, Inc. $AME Bought by M.D. Sass LLC

AMETEK logo with Technology background
Image from MarketBeat Media, LLC.

M.D. Sass LLC purchased a new stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 333,370 shares of the technology company's stock, valued at approximately $80,656,000. AMETEK accounts for 5.3% of M.D. Sass LLC's holdings, making the stock its 5th biggest position. M.D. Sass LLC owned approximately 0.15% of AMETEK at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of AME. JLB & Associates Inc. purchased a new stake in shares of AMETEK during the 2nd quarter worth about $13,458,000. Meeder Advisory Services Inc. purchased a new position in shares of AMETEK in the 2nd quarter valued at about $1,339,000. Meeder Asset Management Inc. acquired a new position in AMETEK in the 2nd quarter worth about $728,000. Citizens Financial Group Inc. RI acquired a new position in AMETEK in the 2nd quarter worth about $700,000. Finally, Cornerstone Advisors LLC purchased a new position in AMETEK during the second quarter worth approximately $7,187,000. Institutional investors and hedge funds own 87.43% of the company's stock.

Analyst Upgrades and Downgrades

AME has been the subject of a number of recent analyst reports. TD Cowen restated a "buy" rating on shares of AMETEK in a research report on Thursday, August 6th. Barclays increased their target price on AMETEK from $220.00 to $230.00 and gave the company an "equal weight" rating in a research report on Monday, May 4th. Rothschild & Co Redburn set a $265.00 price target on shares of AMETEK in a research note on Thursday, June 18th. Robert W. Baird set a $275.00 price objective on shares of AMETEK in a report on Wednesday, August 5th. Finally, Citigroup lifted their target price on shares of AMETEK from $257.00 to $261.00 and gave the company a "neutral" rating in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, AMETEK currently has a consensus rating of "Moderate Buy" and an average target price of $266.80.

Check Out Our Latest Research Report on AME

AMETEK Stock Performance

NYSE AME opened at $250.21 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.21 and a quick ratio of 0.76. The stock's 50 day simple moving average is $239.95 and its 200-day simple moving average is $231.70. The company has a market cap of $57.35 billion, a PE ratio of 36.58, a price-to-earnings-growth ratio of 3.26 and a beta of 0.98. AMETEK, Inc. has a 1-year low of $179.24 and a 1-year high of $261.16.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.99 by $0.10. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The firm had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $1.95 billion. During the same period in the previous year, the business earned $1.78 earnings per share. The firm's revenue for the quarter was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. As a group, equities research analysts anticipate that AMETEK, Inc. will post 8.33 EPS for the current fiscal year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.5%. AMETEK's dividend payout ratio is presently 19.88%.

Insider Activity at AMETEK

In other news, insider David F. Hermance sold 6,608 shares of the firm's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $254.00, for a total value of $1,678,432.00. Following the transaction, the insider directly owned 42,509 shares of the company's stock, valued at approximately $10,797,286. This trade represents a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.54% of the stock is owned by company insiders.

AMETEK Company Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Articles

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in AMETEK Right Now?

Before you consider AMETEK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.

While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines